- Home
- LPTH vs OABI Comparison
LPTH vs OABI Comparison
Compare LPTH & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- OABI
- Stock Information
- Founded
- LPTH 1985
- OABI 2012
- Country
- LPTH United States
- OABI United States
- Employees
- LPTH N/A
- OABI N/A
- Industry
- LPTH Semiconductors
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- OABI Health Care
- Exchange
- LPTH Nasdaq
- OABI Nasdaq
- Market Cap
- LPTH 229.5M
- OABI 227.4M
- IPO Year
- LPTH 1996
- OABI N/A
- Fundamental
- Price
- LPTH $8.87
- OABI $1.66
- Analyst Decision
- LPTH Strong Buy
- OABI Strong Buy
- Analyst Count
- LPTH 3
- OABI 3
- Target Price
- LPTH $6.83
- OABI $6.67
- AVG Volume (30 Days)
- LPTH 1.9M
- OABI 595.9K
- Earning Date
- LPTH 11-06-2025
- OABI 11-11-2025
- Dividend Yield
- LPTH N/A
- OABI N/A
- EPS Growth
- LPTH N/A
- OABI N/A
- EPS
- LPTH N/A
- OABI N/A
- Revenue
- LPTH $37,202,630.00
- OABI $23,027,000.00
- Revenue This Year
- LPTH $50.36
- OABI N/A
- Revenue Next Year
- LPTH $7.77
- OABI $48.74
- P/E Ratio
- LPTH N/A
- OABI N/A
- Revenue Growth
- LPTH 17.26
- OABI 6.05
- 52 Week Low
- LPTH $1.40
- OABI $1.22
- 52 Week High
- LPTH $9.34
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- LPTH 69.28
- OABI 49.38
- Support Level
- LPTH $6.47
- OABI $1.58
- Resistance Level
- LPTH $8.40
- OABI $1.72
- Average True Range (ATR)
- LPTH 0.70
- OABI 0.08
- MACD
- LPTH 0.06
- OABI 0.02
- Stochastic Oscillator
- LPTH 85.46
- OABI 65.15
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.